|
Status |
Public on Dec 14, 2022 |
Title |
Plasma_cells_Multiple_Myeloma [T03417] |
Sample type |
genomic |
|
|
Source name |
sorted Plasma cells, from bone marrow of newly diagnosed multiple myeloma patients
|
Organism |
Homo sapiens |
Characteristics |
subject id: T03417 diagnosis: multiple myeloma Sex: male age: 44 del1p32 status: 0 treatment: VTD-MEL200-VTD tissue: bone marrow cell type: sorted plasma cells (CD138+)
|
Treatment protocol |
sorted plasma cells (CD138+) then frozen (-80°C)
|
Extracted molecule |
genomic DNA |
Extraction protocol |
Nucleospin Tissue Macherey Nagel
|
Label |
biotin
|
Label protocol |
Cytoscan Affymetrix Label (DNA labeling reagent)
|
|
|
Hybridization protocol |
Cytoscan HD arrays (Affymetrix)
|
Scan protocol |
Scanner Affymetrix GCS 3000 7G
|
Data processing |
analysis with the logarithm of ChAS software
|
|
|
Submission date |
Oct 26, 2022 |
Last update date |
Dec 14, 2022 |
Contact name |
Laura Do Souto Ferreira |
E-mail(s) |
dosoutoferreira.laura@iuct-oncopole.fr
|
Organization name |
IUCT
|
Lab |
Equipe 13 : Hematologie
|
Street address |
1 Av. Irène Joliot-Curie
|
City |
Toulouse |
ZIP/Postal code |
31100 |
Country |
France |
|
|
Platform ID |
GPL16131 |
Series (1) |
GSE216574 |
Double-deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor |
|